Trial Profile
Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Mar 2016
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Therapeutic Use
- 24 Mar 2016 New trial record